Estrogen receptor (ER)-mediated activation by endocrine disrupting chemicals (EDCs)

References

• Henley DV, Korach KS. Physiological effects and mechanisms of action of endocrine disrupting chemicals that alter estrogen signaling. Hormones (Athens) 2010; 9:191 - 205; PMID: 20688617
   PubMedGoogle Scholar
• Diamanti-Kandarakis E, Bourguignon JP, Giudice LC, Hauser R, Prins GS, Soto AM, Zoeller RT, Gore AC. Endocrine-disrupting chemicals: an Endocrine Society scientific statement. Endocr Rev 2009; 30:293 - 342; http://dx.doi.org/10.1210/er.2009-0002; PMID: 19502515
   PubMed Web of Science ®Google Scholar
• Golden RJ, Noller KL, Titus-Ernstoff L, Kaufman RH, Mittendorf R, Stillman R, Reese EA. Environmental endocrine modulators and human health: an assessment of the biological evidence. Crit Rev Toxicol 1998; 28:109 - 227; http://dx.doi.org/10.1080/10408449891344191; PMID: 9557209
   PubMed Web of Science ®Google Scholar
• Hughes CL Jr.. Phytochemical mimicry of reproductive hormones and modulation of herbivore fertility by phytoestrogens. Environ Health Perspect 1988; 78:171 - 4; http://dx.doi.org/10.1289/ehp.8878171; PMID: 3203635
   PubMed Web of Science ®Google Scholar
• Omiecinski CJ, Vanden Heuvel JP, Perdew GH, Peters JM. Xenobiotic metabolism, disposition, and regulation by receptors: from biochemical phenomenon to predictors of major toxicities. Toxicol Sci 2011; 120:Suppl 1 S49 - 75; http://dx.doi.org/10.1093/toxsci/kfq338; PMID: 21059794
   PubMed Web of Science ®Google Scholar
• Hall JM, McDonnell DP. Coregulators in nuclear estrogen receptor action: from concept to therapeutic targeting. Mol Interv 2005; 5:343 - 57; http://dx.doi.org/10.1124/mi.5.6.7; PMID: 16394250
   PubMed Web of Science ®Google Scholar
• Li Y, Luh CJ, Burns KA, Arao Y, Jiang Z, Teng CT, Tice RR, Korach KS. Endocrine-Disrupting Chemicals (EDCs): In Vitro Mechanism of Estrogenic Activation and Differential Effects on ER Target Genes. Environ Health Perspect 2013; 121:459-66, 66e1-6.
   Google Scholar
• Wetherill YB, Akingbemi BT, Kanno J, McLachlan JA, Nadal A, Sonnenschein C, Watson CS, Zoeller RT, Belcher SM. In vitro molecular mechanisms of bisphenol A action. Reprod Toxicol 2007; 24:178 - 98; http://dx.doi.org/10.1016/j.reprotox.2007.05.010; PMID: 17628395
   PubMed Web of Science ®Google Scholar
• Rubin BS. Bisphenol A: an endocrine disruptor with widespread exposure and multiple effects. J Steroid Biochem Mol Biol 2011; 127:27 - 34; http://dx.doi.org/10.1016/j.jsbmb.2011.05.002; PMID: 21605673
   PubMed Web of Science ®Google Scholar
• Matsushima A, Liu X, Okada H, Shimohigashi M, Shimohigashi Y. Bisphenol AF is a full agonist for the estrogen receptor ERalpha but a highly specific antagonist for ERbeta. Environ Health Perspect 2010; 118:1267 - 72; http://dx.doi.org/10.1289/ehp.0901819; PMID: 20427257
   PubMed Web of Science ®Google Scholar
• Hewitt SC, Korach KS. Estrogenic activity of bisphenol A and 2,2-bis(p-hydroxyphenyl)-1,1,1-trichloroethane (HPTE) demonstrated in mouse uterine gene profiles. Environ Health Perspect 2011; 119:63 - 70; http://dx.doi.org/10.1289/ehp.1002347; PMID: 20826375
   PubMed Web of Science ®Google Scholar
• Li Y, Burns KA, Arao Y, Luh CJ, Korach KS. Differential estrogenic actions of endocrine-disrupting chemicals bisphenol A, bisphenol AF, and zearalenone through estrogen receptor α and β in vitro. Environ Health Perspect 2012; 120:1029 - 35; http://dx.doi.org/10.1289/ehp.1104689; PMID: 22494775
   PubMed Web of Science ®Google Scholar
• Melnick R, Lucier G, Wolfe M, Hall R, Stancel G, Prins G, Gallo M, Reuhl K, Ho SM, Brown T, et al. Summary of the National Toxicology Program’s report of the endocrine disruptors low-dose peer review. Environ Health Perspect 2002; 110:427 - 31; http://dx.doi.org/10.1289/ehp.02110427; PMID: 11940462
   PubMedGoogle Scholar
• Vandenberg LN, Colborn T, Hayes TB, Heindel JJ, Jacobs DR Jr., Lee DH, Shioda T, Soto AM, vom Saal FS, Welshons WV, et al. Hormones and endocrine-disrupting chemicals: low-dose effects and nonmonotonic dose responses. Endocr Rev 2012; 33:378 - 455; http://dx.doi.org/10.1210/er.2011-1050; PMID: 22419778
   PubMed Web of Science ®Google Scholar
• Hugo ER, Brandebourg TD, Woo JG, Loftus J, Alexander JW, Ben-Jonathan N. Bisphenol A at environmentally relevant doses inhibits adiponectin release from human adipose tissue explants and adipocytes. Environ Health Perspect 2008; 116:1642 - 7; http://dx.doi.org/10.1289/ehp.11537; PMID: 19079714
   PubMed Web of Science ®Google Scholar
• Makaji E, Raha S, Wade MG, Holloway AC. Effect of environmental contaminants on Beta cell function. Int J Toxicol 2011; 30:410 - 8; http://dx.doi.org/10.1177/1091581811405544; PMID: 21705745
   PubMed Web of Science ®Google Scholar
• Ohta R, Takagi A, Ohmukai H, Marumo H, Ono A, Matsushima Y, Inoue T, Ono H, Kanno J. Ovariectomized mouse uterotrophic assay of 36 chemicals. J Toxicol Sci 2012; 37:879 - 89; http://dx.doi.org/10.2131/jts.37.879; PMID: 23037998
   PubMed Web of Science ®Google Scholar
• Liao C, Liu F, Alomirah H, Loi VD, Mohd MA, Moon HB, Nakata H, Kannan K. Bisphenol S in urine from the United States and seven Asian countries: occurrence and human exposures. Environ Sci Technol 2012; 46:6860 - 6; http://dx.doi.org/10.1021/es301334j; PMID: 22620267
   PubMed Web of Science ®Google Scholar
• Golub MS, Wu KL, Kaufman FL, Li LH, Moran-Messen F, Zeise L, Alexeeff GV, Donald JM. Bisphenol A: developmental toxicity from early prenatal exposure. Birth Defects Res B Dev Reprod Toxicol 2010; 89:441 - 66; http://dx.doi.org/10.1002/bdrb.20275; PMID: 21136531
   PubMed Web of Science ®Google Scholar
• Dang ZC. Dose-dependent effects of soy phyto-oestrogen genistein on adipocytes: mechanisms of action. Obes Rev 2009; 10:342 - 9; http://dx.doi.org/10.1111/j.1467-789X.2008.00554.x; PMID: 19207876
   PubMed Web of Science ®Google Scholar
• Kuiper GG, Lemmen JG, Carlsson B, Corton JC, Safe SH, van der Saag PT, van der Burg B, Gustafsson JA. Interaction of estrogenic chemicals and phytoestrogens with estrogen receptor beta. Endocrinology 1998; 139:4252 - 63; http://dx.doi.org/10.1210/en.139.10.4252; PMID: 9751507
   PubMed Web of Science ®Google Scholar
• Nagaraju GP, Zafar SF, El-Rayes BF. Pleiotropic effects of genistein in metabolic, inflammatory, and malignant diseases. Nutr Rev 2013; 71:562 - 72; http://dx.doi.org/10.1111/nure.12044; PMID: 23865800
   PubMed Web of Science ®Google Scholar
• Birt DF, Hendrich S, Wang W. Dietary agents in cancer prevention: flavonoids and isoflavonoids. Pharmacol Ther 2001; 90:157 - 77; http://dx.doi.org/10.1016/S0163-7258(01)00137-1; PMID: 11578656
   PubMed Web of Science ®Google Scholar
• Adjakly M, Ngollo M, Boiteux JP, Bignon YJ, Guy L, Bernard-Gallon D. Genistein and daidzein: different molecular effects on prostate cancer. Anticancer Res 2013; 33:39 - 44; PMID: 23267126
   PubMed Web of Science ®Google Scholar
• Si H, Liu D. Phytochemical genistein in the regulation of vascular function: new insights. Curr Med Chem 2007; 14:2581 - 9; http://dx.doi.org/10.2174/092986707782023325; PMID: 17979711
   PubMed Web of Science ®Google Scholar